Patents by Inventor Xiaolan Qian

Xiaolan Qian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11919170
    Abstract: The present teaching relates to a method and system for path planning. Information of a current pose of a robotic arm having a plurality of operable segments is obtained. The information includes a plurality of values, each of which corresponds to an angle formed between consecutive operable segments of the robotic arm. A desired pose where the robotic arm needs to reach is also obtained. An angle step-value is computed for the current pose of the robotic arm based on a function of a distance between the current pose and the desired pose, wherein the angle step value is to be used to determine a plurality of candidate next poses of the plurality of operable segments. One or more of candidate next poses is selected based on at least one criterion, and a trajectory is determined from the current pose to the desired pose based on the selected next poses.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: March 5, 2024
    Assignee: EDDA TECHNOLOGY, INC.
    Inventors: Yuanfeng Mao, Guo-Qing Wei, Firdous Saleheen, Li Fan, Xiaolan Zeng, Jianzhong Qian
  • Publication number: 20100166707
    Abstract: Disclosed are methods involving the administration of an extracellular matrix (ECM)/metastasis modifier gene, e.g., Anakin, Necdin, CentaurinD3 (CentD3), Csf1r, Brd4, Pi16, and Luc7l, for the prevention or inhibition of metastasis or of tumor growth. Further disclosed are methods of characterizing a tumor or cancer in a subject comprising detecting (i) a single nucleotide polymorphism (SNP) in an Anakin gene or a Brd4 gene of the subject, (ii) an amino acid substitution in an Anakin protein in the subject, or (iii) a level of expression of an Anakin gene or a Brd4 gene in the subject. Methods of screening a compound for anti-cancer activity and use of a compound with anti-cancer activity for the preparation of a medicament to treat or prevent cancer in a subject are also disclosed. Also disclosed is a method of inhibiting Sipa-1 in a subject.
    Type: Application
    Filed: February 23, 2007
    Publication date: July 1, 2010
    Applicants: GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRES, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Kent W. Hunter, Nigel Crawford, Douglas R. Lowy, Xiaolan Qian, Hoda Anton-Culver, Agryrios Ziogas
  • Patent number: 5837523
    Abstract: Nucleic acid molecules that comprise a nucleotide sequence that encodes a protein that dimerizes with epidermal growth factor receptor and p185 and lacks tyrosine kinase activity are disclosed. The nucleic acid molecules in combination with delivery components are disclosed.
    Type: Grant
    Filed: February 11, 1997
    Date of Patent: November 17, 1998
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Mark I. Greene, Xiaolan Qian